Fund Size Strategy

Jan discusses the careful approach to fund size, emphasizing the importance of maintaining a balance to ensure top quartile returns for investors. With a focus on both regulated and unregulated healthcare sectors, he highlights the potential of pharma adjacencies to allow for larger funds while prioritizing investor success over fees. The commitment to returning capital first underscores a dedication to investor interests in a competitive landscape.